205 related articles for article (PubMed ID: 22218923)
1. Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
Farca AM; Miniscalco B; Badino P; Odore R; Monticelli P; Trisciuoglio A; Ferroglio E
Parasitol Res; 2012 Jun; 110(6):2509-13. PubMed ID: 22218923
[TBL] [Abstract][Full Text] [Related]
2. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
[TBL] [Abstract][Full Text] [Related]
3. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
5. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
[TBL] [Abstract][Full Text] [Related]
6. Induction of allopurinol resistance in Leishmania infantum isolated from dogs.
Yasur-Landau D; Jaffe CL; Doron-Faigenboim A; David L; Baneth G
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005910. PubMed ID: 28892476
[TBL] [Abstract][Full Text] [Related]
7. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
8. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol Resistance in Leishmania infantum from Dogs with Disease Relapse.
Yasur-Landau D; Jaffe CL; David L; Baneth G
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004341. PubMed ID: 26735519
[TBL] [Abstract][Full Text] [Related]
10. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
Ayres EDCBS; Dias ÁFLR; Monteiro BRG; Pazzini SS; Barbosa MEC; Silva EBD; Macedo LFDC; Sousa VRF; Dutra V; Nakazato L; Almeida ADBPF
Rev Bras Parasitol Vet; 2022; 31(3):e007222. PubMed ID: 35920471
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
12. Nodular granulomatous glossitis as the sole clinical sign in canine leishmaniosis.
Tangalidi MK; Oikonomidis IL; Psalla D; Papadimitriou S; Kritsepi-Konstantinou M; Mylonakis ME
Vet Clin Pathol; 2016 Dec; 45(4):710-714. PubMed ID: 27755675
[TBL] [Abstract][Full Text] [Related]
13. Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
Travi BL; Cordeiro-da-Silva A; Dantas-Torres F; Miró G
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006082. PubMed ID: 29324838
[TBL] [Abstract][Full Text] [Related]
14. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
[TBL] [Abstract][Full Text] [Related]
15. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
Bhattacharya A; Ouellette M
EBioMedicine; 2018 Nov; 37():13-14. PubMed ID: 30314891
[No Abstract] [Full Text] [Related]
16. Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B.
Valdivieso E; Mejías F; Carrillo E; Sánchez C; Moreno J
Int J Antimicrob Agents; 2018 Nov; 52(5):682-687. PubMed ID: 29969693
[TBL] [Abstract][Full Text] [Related]
17. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
Reimão JQ; Oliveira JC; Trinconi CT; Cotrim PC; Coelho AC; Uliana SR
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
Parasit Vectors; 2021 Jun; 14(1):306. PubMed ID: 34099039
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.
Hendrickx S; Beyers J; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
J Antimicrob Chemother; 2016 Jul; 71(7):1914-21. PubMed ID: 27084919
[TBL] [Abstract][Full Text] [Related]
20. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
de Jong MK; Rappoldt A; Broere F; Piek CJ
Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
